-
1
-
-
0034493155
-
The practice of clinical medicine as an art and as a science
-
Saunders J: The practice of clinical medicine as an art and as a science. Med Humanit 26:18-22, 2000
-
(2000)
Med Humanit
, vol.26
, pp. 18-22
-
-
Saunders, J.1
-
2
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
-
(2005)
Lancet
, vol.365
, pp. 1687-1717
-
-
-
4
-
-
0034680102
-
Molecular portraits of human breast tumours
-
Perou CM, Sorlie T, Eisen MB, et al: Molecular portraits of human breast tumours. Nature 406:747-752, 2000
-
(2000)
Nature
, vol.406
, pp. 747-752
-
-
Perou, C.M.1
Sorlie, T.2
Eisen, M.B.3
-
5
-
-
0037137519
-
A gene-expression signature as a predictor of survival in breast cancer
-
van de Vijver MJ, He YD, van't Veer LJ, et al: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 347:1999-2009, 2002
-
(2002)
N Engl J Med
, vol.347
, pp. 1999-2009
-
-
Van De Vijver, M.J.1
He, Y.D.2
Van't Veer, L.J.3
-
6
-
-
19944422061
-
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer
-
DOI 10.1056/NEJMoa041588
-
Paik S, Shak S, Tang G, et al: A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817-2826, 2004 (Pubitemid 40051905)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.27
, pp. 2817-2826
-
-
Paik, S.1
Shak, S.2
Tang, G.3
Kim, C.4
Baker, J.5
Cronin, M.6
Baehner, F.L.7
Walker, M.G.8
Watson, D.9
Park, T.10
Hiller, W.11
Fisher, E.R.12
Wickerham, D.L.13
Bryant, J.14
Wolmark, N.15
-
7
-
-
2942578063
-
A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen
-
DOI 10.1016/j.ccr.2004.05.015, PII S1535610804001412
-
Ma XJ, Wang Z, Ryan PD, et al: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Cancer Cell 5:607-616, 2004 (Pubitemid 38748922)
-
(2004)
Cancer Cell
, vol.5
, Issue.6
, pp. 607-616
-
-
Ma, X.-J.1
Wang, Z.2
Ryan, P.D.3
Isakoff, S.J.4
Barmettler, A.5
Fuller, A.6
Muir, B.7
Mohapatra, G.8
Salunga, R.9
Tuggle, J.T.10
Tran, Y.11
Tran, D.12
Tassin, A.13
Amon, P.14
Wang, W.15
Wang, W.16
Enright, E.17
Stecker, K.18
Estepa-Sabal, E.19
Smith, B.20
Younger, J.21
Balis, U.22
Michaelson, J.23
Bhan, A.24
Habin, K.25
Baer, T.M.26
Brugge, J.27
Haber, D.A.28
Erlander, M.G.29
Sgroi, D.C.30
more..
-
8
-
-
52049095087
-
A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer
-
Ma XJ, Salunga R, Dahiya S, et al: A five-gene molecular grade index and HOXB13:IL17BR are complementary prognostic factors in early stage breast cancer. Clin Cancer Res 14:2601-2608, 2008
-
(2008)
Clin Cancer Res
, vol.14
, pp. 2601-2608
-
-
Ma, X.J.1
Salunga, R.2
Dahiya, S.3
-
9
-
-
33746910265
-
Concordance among gene-expression-based predictors for breast cancer
-
DOI 10.1056/NEJMoa052933
-
Fan C, Oh DS, Wessels L, et al: Concordance among gene-expression-based predictors for breast cancer. N Engl J Med 355:560-569, 2006 (Pubitemid 44200649)
-
(2006)
New England Journal of Medicine
, vol.355
, Issue.6
, pp. 560-569
-
-
Fan, C.1
Oh, D.S.2
Wessels, L.3
Weigelt, B.4
Nuyten, D.S.A.5
Nobel, A.B.6
Van'T, V.L.J.7
Perou, C.M.8
-
10
-
-
77950494285
-
Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection
-
Lo SS, Murphy PB, Norton J, et al: Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. J Clin Oncol 28:1671-1676, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 1671-1676
-
-
Lo, S.S.1
Murphy, P.B.2
Norton, J.3
-
11
-
-
77950482645
-
Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor - Positive breast cancer: Results from NSABP B-14 and NSABP B-20
-
Mamounas EP, Tang G, Fisher B, et al: Association between the 21-gene recurrence score assay and risk of locoregional recurrence in node-negative, estrogen receptor - positive breast cancer: Results from NSABP B-14 and NSABP B-20. J Clin Oncol 28:1677-1683, 2010
-
(2010)
J Clin Oncol
, vol.28
, pp. 1677-1683
-
-
Mamounas, E.P.1
Tang, G.2
Fisher, B.3
-
12
-
-
39149113165
-
Development of the 21-gene assay and its application in clinical practice and clinical trials
-
DOI 10.1200/JCO.2007.15.1068
-
Sparano JA, Paik S: Development of the 21-gene assay and its application in clinical practice and clinical trials. J Clin Oncol 26:721-728, 2008 (Pubitemid 351264384)
-
(2008)
Journal of Clinical Oncology
, vol.26
, Issue.5
, pp. 721-728
-
-
Sparano, J.A.1
Paik, S.2
-
13
-
-
39749131644
-
Surviving recurrence: Psychological and quality-of-life recovery
-
DOI 10.1002/cncr.23272
-
Yang HC, Thornton LM, Shapiro CL, et al: Surviving recurrence: Psychological and quality-of-life recovery. Cancer 112:1178-1187, 2008 (Pubitemid 351304605)
-
(2008)
Cancer
, vol.112
, Issue.5
, pp. 1178-1187
-
-
Yang, H.-C.1
Thornton, L.M.2
Shapiro, C.L.3
Andersen, B.L.4
-
14
-
-
25144513383
-
Psychological responses to cancer recurrence
-
Andersen BL, Shapiro CL, Farrar WB, et al: Psychological responses to cancer recurrence. Cancer 104:1540-1547, 2005
-
(2005)
Cancer
, vol.104
, pp. 1540-1547
-
-
Andersen, B.L.1
Shapiro, C.L.2
Farrar, W.B.3
-
15
-
-
0025914840
-
Significance of ipsilateral breast tumour recurrence after lumpectomy
-
Fisher B, Anderson S, Fisher ER, et al: Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338:327-331, 1991
-
(1991)
Lancet
, vol.338
, pp. 327-331
-
-
Fisher, B.1
Anderson, S.2
Fisher, E.R.3
-
16
-
-
33646454600
-
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five national surgical adjuvant breast and bowel project node-positive adjuvant breast cancer trials
-
DOI 10.1200/JCO.2005.04.3273
-
Wapnir IL, Anderson SJ, Mamounas EP, et al: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 24:2028-2037, 2006 (Pubitemid 46622111)
-
(2006)
Journal of Clinical Oncology
, vol.24
, Issue.13
, pp. 2028-2037
-
-
Wapnir, I.L.1
Anderson, S.J.2
Mamounas, E.P.3
Geyer Jr., C.E.4
Jeong, J.-H.5
Tan-Chiu, E.6
Fisher, B.7
Wolmark, N.8
-
17
-
-
29144475553
-
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials
-
DOI 10.1016/S0140-6736(05)67887-7, PII S0140673605678877
-
Clarke M, Collins R, Darby S, et al: Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: An overview of the randomised trials. Lancet 366:2087-2106, 2005 (Pubitemid 41797643)
-
(2005)
Lancet
, vol.366
, Issue.9503
, pp. 2087-2106
-
-
Abe, O.1
Abe, R.2
Enomoto, K.3
Kikuchi, K.4
Koyama, H.5
Masuda, H.6
Nomura, Y.7
Sakai, K.8
Sugimachi, K.9
Tominaga, T.10
Uchino, J.11
Yoshida, M.12
Haybittle, J.L.13
Davies, C.14
Harvey, V.J.15
Holdaway, T.M.16
Kay, R.G.17
Mason, B.H.18
Forbes, J.F.19
Wilcken, N.20
Gnant, M.21
Jakesz, R.22
Ploner, M.23
Yosef, H.M.A.24
Focan, C.25
Lobelle, J.P.26
Peek, U.27
Oates, G.D.28
Powell, J.29
Durand, M.30
Mauriac, L.31
Di, L.A.32
Dolci, S.33
Piccart, M.J.34
Masood, M.B.35
Parker, D.36
Price, J.J.37
Hupperets, P.S.G.J.38
Jackson, S.39
Ragaz, J.40
Berry, D.41
Broadwater, G.42
Cirrincione, C.43
Muss, H.44
Norton, L.45
Weiss, R.B.46
Abu-Zahra, H.T.47
Portnoj, S.M.48
Baum, M.49
Cuzick, J.50
Houghton, J.51
Riley, D.52
Mansel, R.E.53
Gordon, N.H.54
Davis, H.L.55
Beatrice, A.56
Mihura, J.57
Naja, A.58
Lehingue, Y.59
Romestaing, P.60
Dubois, J.B.61
Delozier, T.62
Mace, L.J.63
Rambert, P.64
Petruzelka, L.65
Pribylova, O.66
Owen, J.R.67
Harbeck, N.68
Janicke, F.69
Meisner, C.70
Meier, P.71
Howell, A.72
Ribeiro, G.C.73
Swindell, R.74
Burrett, J.75
Clarke, M.76
Collins, R.77
Darby, S.78
Davies, C.79
Elphinstone, P.80
Evans, V.81
Godwin, J.82
Gray, R.83
Harwood, C.84
Hicks, C.85
Jackson, D.86
James, S.87
MacKinnon, E.88
McGale, P.89
McHugh, T.90
Mead, G.91
Morris, P.92
Oulds, J.93
Peto, R.94
Taylor, C.95
Wang, Y.96
Albano, J.97
De, O.C.F.98
Gervasio, H.99
more..
-
18
-
-
34249942379
-
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system
-
DOI 10.1200/JCO.2006.10.3523
-
Hudis CA, Barlow WE, Costantino JP, et al: Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system. J Clin Oncol 25:2127-2132, 2007 (Pubitemid 46972801)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.15
, pp. 2127-2132
-
-
Hudis, C.A.1
Barlow, W.E.2
Costantino, J.P.3
Gray, R.J.4
Pritchard, K.I.5
Chapman, J.-A.W.6
Sparano, J.A.7
Hunsberger, S.8
Enos, R.A.9
Gelber, R.D.10
Zujewski, J.A.11
-
19
-
-
66349105317
-
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer
-
Anderson SJ, Wapnir I, Dignam JJ, et al: Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five national surgical adjuvant breast and bowel project protocols of node-negative breast cancer. J Clin Oncol 27:2466-2473, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 2466-2473
-
-
Anderson, S.J.1
Wapnir, I.2
Dignam, J.J.3
-
20
-
-
0030693661
-
Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor- Positive breast cancer
-
Fisher B, Dignam J, Wolmark N, et al: Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer. J Natl Cancer Inst 89:1673-1682, 1997 (Pubitemid 27508191)
-
(1997)
Journal of the National Cancer Institute
, vol.89
, Issue.22
, pp. 1673-1682
-
-
Fisher, B.1
Dignam, J.2
Wolmark, N.3
DeCillis, A.4
Emir, B.5
Wickerham, D.L.6
Bryant, J.7
Dimitrov, N.V.8
Abramson, N.9
Atkins, J.N.10
Shibata, H.11
Deschenes, L.12
Margolese, R.G.13
-
21
-
-
0042065358
-
Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: Implications for post-mastectomy radiation therapy
-
DOI 10.1016/S0360-3016(03)00431-0
-
Chagpar A, Kuerer HM, Hunt KK, et al: Outcome of treatment for breast cancer patients with chest wall recurrence according to initial stage: Implications for post-mastectomy radiation therapy. Int J Radiat Oncol Biol Phys 57:128-135, 2003 (Pubitemid 36959748)
-
(2003)
International Journal of Radiation Oncology Biology Physics
, vol.57
, Issue.1
, pp. 128-135
-
-
Chagpar, A.1
Kuerer, H.M.2
Hunt, K.K.3
Strom, E.A.4
Buchholz, T.A.5
-
22
-
-
33746932054
-
Predictors of local recurrence after conservative surgery and whole-breast irradiation
-
DOI 10.1007/s10549-006-9169-0
-
Cefaro GA, Genovesi D, Marchese R, et al: Predictors of local recurrence after conservative surgery and whole-breast irradiation. Breast Cancer Res Treat 98:329-335, 2006 (Pubitemid 44195603)
-
(2006)
Breast Cancer Research and Treatment
, vol.98
, Issue.3
, pp. 329-335
-
-
Cefaro, G.A.1
Genovesi, D.2
Marchese, R.3
Ursini, L.A.4
Cianchetti, E.5
Ballone, E.6
Nicola, M.D.7
-
23
-
-
18744393759
-
Predictors of local recurrence after breast-conservation therapy
-
Horst KC, Smitt MC, Goffinet DR, et al: Predictors of local recurrence after breast-conservation therapy. Clin Breast Cancer 5:425-438, 2005
-
(2005)
Clin Breast Cancer
, vol.5
, pp. 425-438
-
-
Horst, K.C.1
Smitt, M.C.2
Goffinet, D.R.3
-
24
-
-
33845808289
-
Predicting a local recurrence after breast-conserving therapy by gene expression profiling
-
Nuyten DS, Kreike B, Hart AA, et al: Predicting a local recurrence after breast-conserving therapy by gene expression profiling. Breast Cancer Res 8:R62, 2006
-
(2006)
Breast Cancer Res
, vol.8
-
-
Nuyten, D.S.1
Kreike, B.2
Hart, A.A.3
-
26
-
-
0035752610
-
Patient preferences for adjuvant chemotherapy of early breast cancer: How much benefit is needed?
-
Simes RJ, Coates AS: Patient preferences for adjuvant chemotherapy of early breast cancer: How much benefit is needed? J Natl Cancer Inst Monogr 30:146-152, 2001
-
(2001)
J Natl Cancer Inst Monogr
, vol.30
, pp. 146-152
-
-
Simes, R.J.1
Coates, A.S.2
-
27
-
-
33750895236
-
TAILORx: Trial assigning individualized options for treatment (Rx)
-
Sparano JA: TAILORx: Trial assigning individualized options for treatment (Rx). Clin Breast Cancer 7:347-350, 2006
-
(2006)
Clin Breast Cancer
, vol.7
, pp. 347-350
-
-
Sparano, J.A.1
-
28
-
-
41649089610
-
Options for slowing the growth of health care costs
-
Mongan JJ, Ferris TG, Lee TH: Options for slowing the growth of health care costs. N Engl J Med 358:1509-1514, 2008
-
(2008)
N Engl J Med
, vol.358
, pp. 1509-1514
-
-
Mongan, J.J.1
Ferris, T.G.2
Lee, T.H.3
-
29
-
-
67651149757
-
Prioritizing comparative-effectiveness research: IOM recommendations
-
Iglehart JK: Prioritizing comparative-effectiveness research: IOM recommendations. N Engl J Med 361:325-328, 2009
-
(2009)
N Engl J Med
, vol.361
, pp. 325-328
-
-
Iglehart, J.K.1
-
30
-
-
52049089470
-
Does Oncotype DX recurrence score effect management of patients with early stage breast cancer
-
Asad J, Jacobson AF, Estabrook A, et al: Does Oncotype DX recurrence score effect management of patients with early stage breast cancer. Am J Surg 196:527-529, 2008
-
(2008)
Am J Surg
, vol.196
, pp. 527-529
-
-
Asad, J.1
Jacobson, A.F.2
Estabrook, A.3
-
31
-
-
42649098952
-
Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer
-
DOI 10.1200/JOP.0742001
-
Oratz R, Paul D, Cohn AL, Sedlacek SM: Impact of a commercial reference laboratory test recurrence score on decision making in early-stage breast cancer. Journal of Oncology Practice 3:182-186, 2007 (Pubitemid 351593669)
-
(2007)
Journal of Oncology Practice
, vol.3
, Issue.4
, pp. 182-186
-
-
Oratz, R.1
Paul, D.2
Cohn, A.L.3
Sedlacek, S.M.4
-
32
-
-
33947196825
-
Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: An economic analysis based on prognostic and predictive validation studies
-
DOI 10.1002/cncr.22506
-
Lyman GH, Cosler LE, Kuderer NM, et al: Impact of a 21-gene RT-PCR assay on treatment decisions in early-stage breast cancer: An economic analysis based on prognostic and predictive validation studies. Cancer 109:1011-1018, 2007 (Pubitemid 46435378)
-
(2007)
Cancer
, vol.109
, Issue.6
, pp. 1011-1018
-
-
Lyman, G.H.1
Cosler, L.E.2
Kuderer, N.M.3
Hornberger, J.4
-
33
-
-
51649110952
-
Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features
-
Goldstein LJ, Gray R, Badve S, et al: Prognostic utility of the 21-gene assay in hormone receptor-positive operable breast cancer compared with classical clinicopathologic features. J Clin Oncol 26:4063-4071, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 4063-4071
-
-
Goldstein, L.J.1
Gray, R.2
Badve, S.3
-
34
-
-
51649121333
-
An ideal prognostic test for estrogen receptor-positive breast cancer?
-
Paik S, Tang G, Fumagalli D: An ideal prognostic test for estrogen receptor-positive breast cancer? J Clin Oncol 26:4058-4059, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 4058-4059
-
-
Paik, S.1
Tang, G.2
Fumagalli, D.3
|